The collaboration will assess and support 25 clinical trial sites across emerging research geographies, with training, ...
Dr Ashok Patel, Aesthetic Surgeon, Founder and Chief Medical Officer, Brilliance Cosmocare, explains how AI is shaping skin ...
The patent covers compounds that inhibit V-ATPase and their use in the manufacture of medicaments for treating viral ...
The agreement sets licensed launch dates for Biocon’s pertuzumab biosimilar in the EU, UK, US and other markets ...
The relationship between dermatology and aesthetic medicine is one of the most compelling issues in recent years. Dermatology ...
The company will use the capital to develop its R&D and technology capabilities, proprietary processes, scale-up capabilities ...
Dr Villoo Morawala Patell, founder of Avesthagen and Avestagenome Project International, discusses how India can turn its ...
As production becomes more complex and highly regulated, digitalisation and automation are emerging as critical enablers. G ...
The US remains a key market for Indian pharma. But changing conditions are pushing India to diversify its global footprint.
Zydus Lifesciences (Zydus) and Formycon AG (Formycon) have announced that the US Food and Drug Administration (USFDA) has accepted for review the Biologics License Application (BLA) for FYB206, a ...
Cohance Lifesciences, a technology-driven, integrated contract development and manufacturing organisation (CDMO), has ...
Akums Drugs & Pharma Ltd., a contract development and manufacturing organisation (CDMO), has introduced a portfolio of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results